Boron supplement for bone strength in postmenopausal women
Part of Bones, joints & muscles, Hormones & metabolism clinical trials.
This study tests a boron-based supplement called OsteoBor to see if it helps strengthen bones in women with postmenopausal osteoporosis. Participants will take either OsteoBor or a placebo along with calcium and vitamin D, and researchers will track bone density changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 45 and 85 years old, past menopause for at least 1 year.
- Your bone density T-score is between -2.5 and -3.5 (meaning you have osteoporosis but not extremely severe).
- You are generally healthy with no major diseases that affect your bones.
- You agree to take the study supplement (OsteoBor or placebo) plus calcium and vitamin D every day for the study period.
- You have not had a hip fracture or multiple spine fractures, and no other fracture (except fingers, toes, skull) in the past 2 years.
- You have not used certain bone medications like bisphosphonates (oral or IV) recently, or other bone drugs like denosumab or teriparatide in the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well your blood vessels work and how strong your muscles are, in women after menopause with osteoporosis. You may be asked to start standard osteoporosis treatment, and the researchers will study pain and changes related to vascular function and sarcopenia (loss of muscle and strength).
This study tests a new supplement called CL22205 to see if it can improve bone density and help with menopausal symptoms. It is designed for women aged 55-65 who have gone through menopause and have early bone loss (osteopenia).
This study tests a new form of calcium (amorphous calcium carbonate) to see if it can improve bone density in postmenopausal women with osteoporosis. It may offer an alternative for women who cannot or choose not to take other osteoporosis medications.
This trial tests whether a specific exercise program (circuit training) can improve bone density in women after menopause who have low bone mass. It may help strengthen bones and reduce fracture risk.
This study tests whether a daily probiotic supplement can help prevent bone loss in adults aged 60 and older. It is designed for people who have chosen not to take standard osteoporosis medications.
This study compares two treatment plans for women with osteoporosis to see which one improves hip bone density more. Participants will either get two medications in sequence (romosozumab followed by denosumab) or one medication (zoledronic acid), both given as injections or infusions. The goal is to find a treatment that reduces fracture risk.
Hear when a new Osteoporosis, Postmenopausal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.